4.23 Access to Cancer Medicines, Standard of Care in Oncology, and the Oncology Value Paradigm

Plenary Session

Vinay Prasad, MD MPH

Health, Medicine, Policy, Oncology, Science & Medicine

4.7 • 789 Ratings

🗓️ 15 October 2021

⏱️ 88 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

On today's episode we're joined by a number of special guests: Dr. Christopher Booth and Dr. Adam Fundytus of Queen's University in Kingston, Ontario, Dr. Manju Sengar of the Tata Memorial Centre, and Dr. Aaron Goodman of the University of California at San Diego. We talk about their new papers: "Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey", "Practicing on the edge of oncology: when standard of care feels uncomfortable", and "Has the Current Oncology Value Paradigm Forgotten Patients’ Time? Too Little of a Good Thing". Cancer Medicines: doi.org/10.1016/S1470-2045(21)00463-0 Edge of Oncology: doi.org/10.1038/s41571-021-00550-9 Value Paradigm: doi.org/10.1001/jamaoncol.2021.3600 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Plenary Session.
0:07.9	I'm Vinay Prasad. I'm an associate professor with University of California, San Francisco.
0:11.9	I'm a practicing he-mong doctor, and my interests are medicine, oncology, and health policy.
0:16.4	And that's what you're going to get on Plenary Session.
0:21.6	This is season four, hashtag zero COVID.
0:24.6	It's zero COVID because we're not going to talk about COVID.
0:26.6	We're back, oncology, medicine, health policy.
0:29.6	We've got a lot in store for you.
0:33.6	But first, a plug.
0:34.6	If you like this podcast, leave us a rating or write us a review. It helps new listeners find the show. You can follow us on Twitter at Plenary underscore Session. You can email us at plenary session podcast at gmail.com. Give us your suggestions on what we should be covering. And we got a new YouTube channel, Vinay Prasad, MDMPH. Follow us on YouTube. I'm putting up a 10-part series on reading and interpreting cancer clinical trials.
0:57.6	You'll want to watch it there.
1:00.0	And if you really love this show, you can back us on patreon.com.
1:03.8	Patreon backers get access to slides for lectures I give on Plenary Session.
1:07.8	And with that, let's start the show.
1:13.3	I'm back in Plenary session, virtual edition.
1:17.7	I'm joined by Chris Booth, and he's going to be introducing our new guest on this podcast.
1:22.4	They have a new paper out. It's coming in the Lancet Oncology. Chris, friend of the show, Kingston,
1:25.7	Ontario, Canada, Professor of Medicine. It's good to see you, my friend.
1:28.8	Thanks, Benai. Thanks for having us back.
1:34.3	And it's a great pleasure and privilege to have my friend and colleague, Dr. Manjou Sengar, join us.
1:40.5	I've known Manjou for many years. She is a senior hematologist at the Tata Memorial Center in Mumbai.
1:45.6	And I got to know Manjou through working very closely with her at the Credo Methods Workshop, where she's one of the organizers. This is a wonderful one-week cancer research methodology
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.